STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
SMMT SUMMIT THERAPEUTICS INCORPORATED StockScouter® Report
3
StockScouter® Score
SUMMIT THERAPEUTICS INCORPORATED, a mid cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Two or more executives, directors or major shareholders – including one high-level executive -- purchased a large number of shares recently. Very positive
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- One or more analysts has significantly decreased quarterly earnings estimates for SMMT. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
A
N/A
B